EP Patent

EP3110430B1 — Use of a casein hydrolysate as an antiviral agent

Assigned to NTD Labs SL · Expires 2019-06-26 · 7y expired

What this patent protects

Patent listed against Zovirax.

Drugs covered by this patent

Patent Metadata

Patent number
EP3110430B1
Jurisdiction
EP
Classification
—
Expires
2019-06-26
Drug substance claim
No
Drug product claim
No
Assignee
NTD Labs SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.